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This study is concerned with the toxicity of hexachlorophene, a 
long-used disinfectant that, until recently, was found in many soaps and 
cosmetics. The primary purpose is to show that young animals, in this 
case mice, are much more susceptible to the toxic effects of hexachloro-
phene than are adult animals. The study was prompted by the recent ban 
by the United States Food and Drug Administration on the use of hexochlo~ 
rophene in all products except prescription items. It is hoped that this 
experimental data will provide evidence that hexachlorophene may be safe 
for use in products available to adult humans. 
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INTRO DUCT ION 
Hexachlorophene (HCP) has been widely used since the mid-1940's as a 
powerful antibacterial agent. It has been.incQrporated in antiseptic 
agents; baby powders, after.shave lotions, deodorants, tooth paste, and 
many other non-prescription items available to the general public. Other 
uses included broad spectrum fungicides and bactericides used on fQod 
crops. Perhaps the most important use of HCP during the past thirty 
years was its incorporation into germicidal soaps used for surgical 
s.crubs and infant care. The drug _was found to be quite effective in con-. 
trolling populations of gram-positive organisms in hospital nurseries 
(18,19,44,SO,Sl). 
For many years HCP was thought to be.essentially non-toxic to 
humans. It was used as 1-3% conc~ntrations in soap in most of the hospi.-
tal nurseries in the co~ntry. Many surgeons used it several times daily 
for antibacterial scrubs prior to surgery (60), It was thought to be so 
safe and effective as an antibacterial agent that it _was included in many 
cosmetics. 
Numerous toxicity studies had been conducted in.laboratory animals. 
Tqxic reactions.were.shown in rats, mice, guinea pigs, dogs, sheep, and 
cattle (8,13,14,20,21,25,27,S2,S3). However, recognition of significant 
degrees of HCP toxicity in humans was slow in forthcoming. Gradually, 
over a 27-year period, evidence of human toxicity began to emerge. 
1 
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Reports of cutaneous.reactions, neurologic episodes and death due to 
HCP toxicity began to accumulate (1,4,21,27,28,30,33,36,40,59), In 
December, 1971, the United States Food and Drug Administration (FDA) sent 
a drug bulletin to 600,000 doctors and other health professionals warn .. 
ing them to discontinue use of HCP products in routine bathing of infants 
and adults (SS). On January 6, 1972, the FDA announced in a press 
release that all skin cleansing products containing more than 0.75% HCP 
would be restricted to prescription use only (56), 
To the general public, the almost complete removal of HCP from the 
public marketplace seemed to be an over-reaction on the ._part of the FDA. 
Most studies to determine the irritating and s~nsitizing properties of 
various topical HGP preparations on human skin had produced no evidence 
of lesions (21). Hexachlorophene was used in hundreds of products by a. 
very large number of people in the United States .and foreign countries, 
but remarkably few cases of irritation and allergy were reported. Sever-. . ' 
al million cakes of deodorant soap were used by the. general pub lie with 
no reports of proven ca~es of sensitization. 
The reported cases of toxicity of HCP in huma~s have been, in almost 
all cases, ass9ciated with misuse of the dru~. Accidental ingestion of 
the drug caused some morbidity and rare fatalities (3,30,40,59), Appli.-
cations of higher-than-recommended concentrations to the skin or failure 
to rinse the chemical from the skin accounted for most other reported 
c~ses ~f toxicity (4,22,28,33,42). 
The majority of deaths associated with HCP toxicity have be~n in. 
infants (40,41). In 1972, in France, thirty-nine babies died from appli-
cations of a baby_powder accidentally containing 6% HCP, which was double 
the usual level (3,41,42). The de~ths of fifteen persons in the United 
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States due to HCP during the· period 1954-1971 were reported in September, 
1972, by the FDA and publicized in the newspapers across the United 
States.in an article syndicated by the As~oci~ted Press (3). 
In imposing the restrictions on HCP use, the FDA used as its basis 
th1ee recent reports. The first was in August, 1971, in which Kimbrough 
and Gaines (26) reported that rats fed HCP in their diet developed leg 
weakness which progressed to paralysis. The second study was conducted 
by Curley, et al. (11) on 50 newborn infants and showed that the infants 
could absorb HCP through the intact skin after being bathed with hexa-
chlorophene soap. The third report was from Sterling Drug, Inc., the 
manufacturer of the most widely used 3% HCP solution, pHisoHe~ (41). 
This -study showed that newborn monkeys bathed in 3.% HCP developed lesions 
in the brain similar to those produced in rats, as reported in the first 
study mentioned above. After considerable weighing of risks and benefits 
of HCP, the FDA decided to place restrictions on the use of the drug. In. 
their decision, the FDA called for additional research to clarify and 
furt~er delineate HCP toxicity effects. 
This thesis reports the results of studies designed to determine the 
effect of age difference in susceptibility to acute HCP toxicity in mice. 
The histopathqlogical lesions observed with acute toxicity in different 
ages of mice are reported. Results are also reported on a third study to 
determine the concentrations.of HCP in brain, liver and blood in differ-




Description of Hexachlorophene, 
The official chemical name of hexachlorophene is 2,2'-methylenebis 
(3,4,6-trichlorophenol). Other reference code terms which have been used 
for HCP include G-11 and AT-7. As can be determined from the chemical 
name, it is a phenolic compound. Hexachlorophene is practically 
insoluble in water, but is soluble in alcohol, acetone, ether, chloro-
form, propylene glycol, vegetable oils, and dilute aqueous solutions of 
alkalies (34). Pure HCP is a white, crystalline powder. It must be 
stored in light-resistant containers, as light will cause chemical 
breakdown (39). 
OH OH 
Cl CH2 Cl 
C13H6c1602 
Cl Cl 




Hexachlorophene was synthesized in 1939 and patented by the Guvaudan 
Corporation in 1941 (20). Commercial production began after World War 
II. The antibacterial qualities of this drug have been well documented 
(6,17,20,37,44,54), Hexachlorophene reduces the bacterial flora of the 
skin through continued daily use of soaps containing this drug in levels 
of 1-3%. Repeated applications at these concentrations allow the build-
up of effective antibacterial levels of the compound on the skin. This 
compound is strongly bacteriostatic and bacteriocidal against 
Staphylococcus aureus and other gram-positive bacteria, but it has con-
siderably lower activity against gram-negative micro-organisms (11,17,44, 
54}. If the compound is used routinely in a regular bathing program, a 
significant reduction in the bacterial flora of the skin occurs. 
In recent years, there has been some controversy over the actual 
effectiveness of HCP. Sarkarny and Arnold (44) observed suppression of 
resident skin flora with no appreciable effect on streptococci and 
Escherichia coli, but an increased frequency of proteus species. Forfar 
(17) found that, although daily use of HCP on newborn infants and on the 
hands of attendant staff reduced neonatal staphyloccal infections, there 
was an accompanying absolute rise in the frequency of infections caused 
by gram-negative bacilli. A study by Evans, et al. (15), using twice 
daily scrubs with HCP soap on the toe web areas of medical student volun-
teers, showed an absolute decrease in the number of aerobic bacteria to 
approximately one third the original level within one week. The main 
reduction was in staphylococci and diptheroids, while at the end of one 
week there was an absolute rise in the number of gram-negative organisms. 
The gram-negative organisms were primarily bacilli, predominantly 
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pseudomonas, enterobacter, and ·klebsiella. These data suggest that one 
effect.of the judicious daily use of HCP-containing soap is to increase 
the amount of gram-negative organisms on the skin, these organisms 
increasing with the decrease of staphylococci and diptheroids. The ques-
tion that arises is whether the use of such soaps on patients during 
several ~ays of hospitalization may actually be increasing the risk of 
hospital-associated infections due to gram-negative bacilli (15). 
White and Duncan (60) explored the comparative effectiveness in. 
preventing post-surgical infections of iodophor versus HCP scrub solu-
tions for presurgical scrubbing of the surgeon's hands and operative area 
of the patient~ Theoretically, the bacteriocidal effects of iodophor 
should be superior .to HCP, which is bacteriostatic, when.used on a one-
time basis, such as in the presurgical preparation of a surgical patient. 
The results of the studies by White and Duncan (60) indicated that there 
was no differeD.ce in the incidence of infection when either of these two 
scrub solutions were used on.a large number of patients and that both 
were acceptable. Custer, et al. (12) studied the comparative effective-
ness of HCP and providine in pre\Tenting infection in contaminated wounds. 
These authors stated both antiseptic agents exerted a favorable influence 
on tbe contaiminated wound but their. beneficial effects were outweigh~~\~", 
by the .harmful effects of the detergent in the scrub solutions. 
Noone, et al. (37) found that a water soluble ointment containing 2% 
H;CP was very effective in eliminating epidemic strains of·Staphylococcus, 
aureus.from nasal passages of known carriers of this organism in a hos-
pital. The ointment was applied twice daily for seven successive days to 
the nasal passages of individuals who were found to be carrying the. 
resistant strains ,of staphylococcus in th~ir nasal passages. The. nasal 
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treatment was accompanied by bathing and washing with HCP soap. At the 
end of the seven day period, no resistant Staphylococcus aureus organisms. 
could be cultured from the nasal passages. It was felt that this pro-
cedure was better for eliminating the resistant organisms than the use of 
antibiotic ointments., which may cause drug sensitivities to develop in 
the carriers and drug resistance .to develop in the bacteria. 
Other Uses of Hexachlorophene 
Hirschler (23) and Dorsman (14) reported on the use of HCP as an 
anthelmintic drug against liverflukes (Fasciola,hepatica) in sheep and 
cattle. The use.of HCP for this purpose has not gained widespread use.in 
the United States, but the reports by these investigators prompted toxi-
cqlogical studies of HCP in the ovine and bovine species (24,43,49,53,61). 
In China, HCP has been used in the treatment of infestation by the· 
liver fluke, Chlornorchia sinensis, in humans (9 ,29), ·. This fluke infes-
tation is transmitt~d to humans by the eating of infected raw fish. 
There has not been an effective treatment for this disease in man. 
In 1969, the use of HCP as a broad-spectrum fungicide and bacterio-
cide on food crops was.reported (35). Its use was also recommended for 
control of rust mites on citrus crops and rhizoctonia in soil. The 
application to the FDA for permission to use HCP in this role prompted 
the toxicological studies which eventually caused the FDA to greatly 
restrict the use .of this drug (42). 
Bacteriostatic Effects of Hexachlorophene 
on the Skin 
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The reduction in.the number of bacteria on the-skin achieved through 
the continued use of HCP preparations has been well established. This is 
attributed to the buildup and retention of effective levels of the com-
pound on the skin (16). Manowitz and Johnston (32) reported on the con-
centrations of HCP retained by the skin under controlled washing 
conditions. In single applications, the amount of residue left on the 
skin after rinsing depended on the percentage.of the drug in the soap, 
There was also a clear indication that the amount of HCP left on the skin 
increased with increased application time of the soap. Approximately 
equivalent.amounts of HCP were retained on the skin whether bathing was 
by shower or by tub bath. Their data also indicated that substantial 
quantities of HCP were deposited on the skin from bathing with .soaps con~ 
taining relatively low concentrations of HCP; It was also found that the 
amount of HCP residue on the skin increas~d with the number of washings 
in a single day or over a four-day period. No plateau effects were noted 
in any of these test~, i.e., the concentration on the skin continued to 
rise with additional washings. 
In contrast, Shemano and Nickerson (47) found that HCP accumulated 
on the.skin during the first three or four washes and remained relatively 
constant thereafter. Compeau (10) showedthat HCP built up during the 
first .five to ten minutes-of sc~ubbing but then accumulated no further 
with additional scrubbing time. He suggested that HCP was adsorbed on 
the skin through an anionic reaction with the cationic pro~eins of the 
skin. M~nowitz (32) disagreed with this, however, and-offered the sug-
gestion from his ·evidence .. that. the quantity of HCP on the skin is due to 
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its physical entrapment by the skin. He stated that the quantity of HCP 
on the skin, and therefore the number of bacteria on the skin, is 
affected more by the mechanics of the washing process and is subject to 
' ' 
great variation due to individual washing habits. 
14 Carroll, et al. (8) reported on the absorption of C-labeled HCP 
through the intact.and injured skin of the tail of rats. 14c-HCP was ab-
sorbed through.the intact tail skin of the rat at an average.rate of 1.7 
micrograms per square centimeter of exposed s~rface per hour.· The tails 
of the rats were immersed for 3 hours in 15 ml of .1% (weight:volume) 
14c-HCP. Imme~iately after the development of second degree burn, the 
average.absorption rate increased tq 2 1/2 times that of normal skin for 
24 hours and then dropped to nonnal or .subnormal rates. A similar pat-
tern of HCP absorption was noted with traumatized rat tails, except that. 
the average rate of.penetration of the isotope went up to 7 times that of 
normal skin. 
A study undertaken by Curley, et al. (11) showed that infants bathed 
in HCP·soap absorbed a significant quantity of .HCP through the normal 
skin. Umbilical cord blood wa$ drawn for electron-capture gas.,.liquid 
chromatography at the time of discharge from the hospital. During their 
1-11 day stays in the hospital, the infants,were washed once daily with 
3% HCP detergent solutions diluted to varying degrees. Some were rinsed 
and some were not, but 45 of 50 infants showed an increase in HCP conc~n-
tration in.the blood.at the time of discharge. Neither weight nC>r sex 
see.med to influen~e the HCP blood levels. 
Larson (28) showed that HCP passed readily through the burned skin 
of humans.bathed with 3% solutions. Other data which .he presented indi-




By far the major use of HCP was in soaps, cosmetics, powders, and 
other preparations which were used on.the skin. Before the FDA banned 
its use, about 4 million pounds of HCP a week were being used by American 
cosmetic and pharmaceutical companies (2). In spite of this vast amount 
of HCP being used on the skin of literally millions of people of all ages 
each day, there were surprisingly few cases of skin reaction to the drug. 
Baker, et al. (4) reported on ten patients who suffered primary 
irritant contact dermatitis of the scrotum due to various. types of HCP 
preparations used on the skin. The patients in this series used the drug 
according to directions furnished them but apparently failed to adequately 
agitate the water to thoroughly mix the solution before bathing the 
affected areas. After withdrawal of the HCP treatment, the lesions re-
gressed rapidly. McDonald and Woodruff (33) reported twelve cases of 
acute scrotal dermatitis following washing of the scrotum with a deter-
gent containing 3% HCP prior to genito-urinary surgery. This did not 
occur if the scrotum was rinsed throughly after the wash. 
Herter (22) described central nervous disturbance and skin reactions 
in a newborn infant who, after being discharged from the hospital, was 
treated by the mother with a 3% HCP lotion after bathing. The lotion was 
left on the skin. After four days excoriations appeare4 on the face and 
buttocks. Nervous involvement was also present. Removal of the lotion 
resulted in remission of all signs. 
Newcomer, et al. (36), in desc~ibing a melanosis of the face termed 
"chloasma", stated that the etiologic factors varied from time to time 
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and.from place to place, but.are generally caused by.externally applie~ 
cosmetics or are of occupational origin. In their study, HCP was the 
only·active ingredient common to the cosmetics employed by each patient. 
However, they were.unable tQ.produce any pigmentation experimentally 
whic~ could be.attributed to HCP. 
Gump (21) cites evidence of skin irritation and systemic toxicity 
associated with experimental topical application of HCP preparations in 
rats, rabbits, .and guinea pigs. When 600 humans were patch .tested with 
0.5 and1% HCP in petrolatum, the results were.all negative. The patch 
test was repeated in the.patients after 10 days to determine whether 
sensitivity might have. been produced. All 600 tests were negative, indi-
cating HCP was non-irritating to the skin and was.not a.sensitizer. 
Another series of 50 subjects.were found to develop erythema when sub-
jected to patch testing with HCP in 80% aqueous propylene glycol (21). 
In another group of 50 persons patch tested with 5% HCP in dimethyl 
phthalate, only one subject showed a continuous reaction in the form of 
slight erythema. Photosensitization due to HCP has·rarely been observed 
(21). 
~ystemic Toxicity 
Since. the synthe.sis of HCP in 1939 anq. its co~erc~al introductton 
a£ter-Wor14 War.II, much data has been ac~umulated on the toxicological 
prope~ties of this drug. Studies have been reported on many different 
animal~~ and observations have been reported on humans tha4 have 
experienced.toxic systemic reactions (21,27). 
A review of the different repo~ts concerning the acute oral L.D._50 
of HCP• in mice indicated that most yalues lie in a narrow range between 
160 and 210 mg/kg (21). The carrier of the HCP in these studies seemed 
to make some difference in the .L. D. 50 , sin.ce. no two reporters used the 
same carrier., A single report on the toxicity of HCP in guinea pigs 
indicated the L.D. 50 to be.somewhere bet~een 250 and 300 mg/kg (20), 
Rats showed a similar L.D. 50 riinge.for acute oral toxicity as for 
mice. The range appeared to be between 146 and 250 mg/kg depending on 
the carrier (21}. Oral administration of HCP to adult ratsat the rate 
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of 25 mg/kg/day for 2 weeks caused paralysis and vacuolation in cerebral 
white matter (26). Similar findings accompanied the oral administration 
of HCP to weanling rats.at the rate of 100 mg/kg (11). Hexachlorophene 
given.orally to adult female rats at the rate of 5 mg/kg/day for 100 days 
caused brain damage in the.adults and decreased the survival of their. 
off spring (11) . 
Dogs are somewhat more susceptible than rats and mice. All of 12 
dogs died after receiving single doses of 140 mg/kg of HCP in gelatin 
capsules . (21). In further tests all dogs survived doses of 100 to 160 
mg/kg, Delak, et al. (13) reported that 10 to 20 mg/kg was tolerated 
without.toxic symptoms. Administration of 30 mg/kg produced toxic signs 
and doses of 40 to 50 mg/kg caused death of most dogs. 
Sheep and cattle .are also more susceptible than rodents. Since 
Hirschler (23) reported.on the anthelmintic properties of HCP·against 
liver flukes., many papers have been published on.the subject (14,21 1 24, 
43,,49,53,61). Doses of 20 mg/kg were well tolerated by cattle, doses of. 
30 and 40 mg/kg gave toxic signs, and death may occur at the higher . ' . 
level (14), Sheep tolerated doses of 100 mg/kg in.one study, but showed 
signs of toxicosis in another study when given doses of 70 to 80 mg/kg 
(21), Jack (24) reports ~uspected HCP toxicity in 20 calves that were· 
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being fed milk from polythene buckets that were also being used for 
udderwash in the milking parlour. Hexachlorophene was used in the udder-
wash. Seven of 20 affected calves died. 
Lusting (30) reported a fatal case of poisoning in a six-year-old 
child who drank 4 or 5 ounces of HCP lotion and died nine hours later, 
It was estimated that the ingested lotion contained approximately 250 mg 
of HCP per kilogram of body weight. Liu, et al, (29), as cited by Wear 
(59), observed some toxic reactions to HCP in eight patients who received 
three successive doses of 20 mg/kg/day, One of these became comatose the 
fourth day, but recovered after three days. The child reported by Herter 
(22) d~veloped twitchings of the arms and legs and later progressed into 
convulsions, This infant developed toxic signs after cutaneous absorp-
tion of the drug. It recovered fully within a week after discontinuance 
of the drug.· Another infant was accidentally given HCP orally daily for 
seve~ days (40}. Neurologic signs developed and persisted for one month 
after withdrawal of the drug. It was estimated that the child received a 
total amount of 250 mg/kg of HCP in divided doses over a period of one 
week or roughly 37 mg/kg/day. In a report by Wear, et al. (59), ten 
persons were known to have ingested HCP accidentally during presurgical 
· preparations. This occurred because the disinfectant (meant to be used 
as a preoperative scrub) was dispensed in a paper cup without adequate 
instructions and supervision by the nurse and because the suspension 
resembles milk of magnesia in color and viscosity, None of the persons 
died as a direct result of the ingestion, but all showed severe gastro-
intestinal aberrations with one person dying of c~rdiac arrest the fol-
lowing day in surgery. 
In a study by Larson (28), blood levels of HCP were determined in 
burned patients to whom 3% HCP detergents had been applied. He found 
that the drug pas.sed readily through the burn wound. When serum levels 
of HCP became sufficiently high, convulsions could result in either the 
child or the adult. Larson also discussed "burn encephalopathy'', which 
he said has been cited frequently in the literature to describe the 
burned patient who developed stupor, coma, confusional status, muscle 
twitching, convulsions and cerebral edema. The literature cites many 
etiologic possibilities, but Larson thought HCP might be the inciting 
factor. He highly reco1Jll1lended thorough rinsing of burned patients when 
HCP is used to control infection in the burned areas.· 
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The signs of systemic HCP toxicity can be divided into two broad 
groups: those associated with disturbances in the nervous system and 
those associated with gastrointestinal tract disturbances, In rodents, 
the signs noted were predominantly neurological. The affected animals 
showed weakness of the rear legs progressing to paralysis, convulsions, 
dyspnea and respiratory paralysis (21,26,27). No gastrointestinal signs 
other than anorexia have been reported in rodents. Neurological signs in 
humans include generalized weakness, muscular twitching, nystagmus, coma 
and convulsions (30,40), Gastrointestinal signs in humans include severe 
vomiting and di~rrhea with accompanying dehydration, abdominal cramps and 
a burning sensation in the throat and stomach (30,40,59). Similar signs 
were noted in,dogs (46). 
Gross and Histopathologic Lesions Associated 
With Systemic Toxicity 
The most.striking histopathologic lesion noted with HCP toxicity was 
edema and vacuolation of the white matter of the brain, This has been 
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seen in rats, mice, guinea pigs, dogs, and humans (21,26,27,38,40), The 
edema and vacuolation of the white matter of the brain appeared to be 
quite similar to that caused by triethyltin compounds (31). Scott, et 
al. (46) found no brain changes in.dogs.given HCP per os, but Ward (58) 
reports a litter of puppies which showed neurological signs and vacuola-
tion of the white matter of the brain after dermal application of a HCP 
preparation which was .not rinsed off. Chung, et al. (9), as noted by 
Gump (21}, reported the brain hac)., at most, small perivascular inflamma-
tory infiltrations. These authors also reported mild degenerative and 
inflammatory.changes of the liver, kidney and lungs in rats. Thorpe (52, 
53) reported findings of periportal fatty change in the sheep liver and 
also reported on testicular degeneration in sheep and rats caused by HCP. 
All lesions, if they did not cause death of the animals, appeared to be 
reversible rather quickly after withdrawal of the drug (25,26,27,31,40, 
46,58). 
Kimbrough and Gaines (26) found that the brains of rats receiving 
HCP at the rate of 25 mg/kg/day for 14 days weighed more than the brains 
of control rats. The average for the treated rats was 2.60 gm, with the 
average for the untreated rats being 1.99 gm. This increase in brain 
weight was.statistically significant (P < 0.001), and helps support.the 
theory of edema of the brain tissue. 
A review of autopsies since.1966 of all children under 5 years at 
the University of Washington revealed a total of 21 infants with a simi-
lar specific vacuolar lesion of the brainstem, including the reticular 
formation (38). A statistically significant association was demonstrated 
between the occurrence of vacuolation of the reticular formation (VRF) 
and three or more exposures to 3% HCP. The lesions were found more 
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frequently in premature infants who were bathed three or more times in 
HCP than in larger infants bathed an equal number or fewer times. 
Lusting (30) reported the gross findi~gs in his fatal case of HCP 
ingestion were "congestion of organs and severe inflammation of the 
stomach". 
There is no known specific antidote for HCP toxicity (30), Treat-
ment consists of inducing vomiting quickly if oral ingestion occurs and, 
th~reafter, to give supportive therapy as needed with special emphasis on 
fluid and electrolyte replacement (30,59). . . . 
Biochemical Effects of Hexachlorophene 
Untq recently, little had been published concerning the biochemical 
effects of HCP at the cellular and subcellular levels. Work done.by 
Carnmer and Moore (7) indicated that HCP uncouples mitochondrial oxidative 
phosphorylation in the liver and brains of rats. Blockus, et al. (5) 
agreed with Carnmer and Moore and stated that HCP toxicity appeared to be 
quite .similar to toxicity caused by 2,4-dinitrophenol. In work on dogs, 
he found an elevated body temperature, increased respiratory rate, and 
decreased carbon dioxide in expired air. Thorpe (53) reported loss of 
alkaHne phosphatase and adenosine triphosphatase activity from the 
periportal zones of the hepatic lobules, He also found reduced succinic 
dehydrogenase and glutamate dehydrogenase activity. He correlated these 
findings with the inhibitory action of HCP on various oxidative enzymes, 
Fate.of Hexachlorophene in the Body 
With only a small amount of work having been reported in this area, 
it appears that orally administered HCP is eliminated primarily in the 
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feces with only minor urinary excretion in rats and cows, but with a sig-
nificant excretion of HCP in th~ urine of rabbits (49,61). In one.,study 
conduct~d by.St. John and Lisk (49), it was.founc;l that no HCP was 
excreted in the .milk of dairy cows. The findings of Wit and Van Genderen 
(61) were in agreement with this, St. John (49) found that HCP did not 
decompose.in ruminal fluids, and that there.was no detectable breakdown. 
of the drug when it was incubated with fresh beef liver. No breakdown 
products of HCP were found in the urine or feces.of these cows. 
Wit and Van Genderen (61) also used rats and rabbits to study the 
fate of HCP in the body. In rabbits they found that approximately one 
third was excreted unchanged in the urine, one third wa$ excreted un-
changed in the feces, and one. third appeared as unidentified metabolite.s 
in the feces~ These latter products could not be extracted from the 
feces with ethanol. Approximately five days were required for the entire 
dose.to be eliminated from the rabbits. Practically no HCP was excreted 




AGE DIFFERENCES IN SUSCEPTIBILITY 
TO HEXACHLOR,OPHENE 
Mortality Differences From Hexachlorophene 
Toxicity in Different Aged Mice 
Hexachlorophene, U.S.P. (39), was obtain~d from Sigma Chemical 
Company. The solve~t used was peanut oil, connnercial grade (Planter's). 
He~achlorophene was added to the peanut oil to make a 1% (weight:volume) 
solution. Approximately 24 hours were required for the HCP to become 
completely dissolved in. the peanut oil. Peanut oil was used as the 
solvent because preliminary studies indicated that peanut oil was non-
toxic to mice. 
Methods 
Five age groups ofSwiss white mice were used: 5, 10 1 15, 30 and 60· 
days of age. In each age group there were subgroups with ten or more 
mice in each subgroup. Each subgroup was given.a different dosage level 
of 1% HCP solution in an atte~pt to establish a single oral minimal 
lethal dose fQr all mice (L.D. 100), a dosage which would ~ill approxi-
mately SO percent of the mice (L.D. 50), and the maximum single oral 
dosage which would kill none of the mice in that age group. Five mice i~ 
18 
19 
each age group were given only peanut oil in the same volu~e as the sub-
group in that age group receiving the highest HCP dosage rate. The mice 
were observed for one week after treatment. During this observation 
period, any signs of toxicity were recorded. Administration of the HCP 
solution was made via a 2-centimeter long polyethylene tube (.043 inch 
outside diameter) passed into the esophagus of the mice and connected to 
a microliter or tuberculin syringe delivery unit. The tuberculin syringe 
was used to deliver doses of solution larger than could be contained in 
the microliter syringe. 
Preliminary studies indicated that the L.o. 50 for the 60-day-old 
mice was approximately 150 milligrams of HCP per kilogram of body weight 
(150 mg/kg). Similar studies in 10-day-old mice indicated the L.o. 50 was 
in the range of 30 mg/kg. Subsequent experimental dosage levels were de-
signed to investigate the intermediate range of approximate L.D. 50 1 s. 
One common dosage level of 90 ~g/kg was used in all age groups. 
The L.o. 50 for each age group was derived by using proportions ac-
cording to the equation A:B = C:D. In this equation, A is the unknown 
difference ip dosage (mg/kg) between the dosage that would kill 50% of 
the mice and the highest dosage that killed less than 50% of the mice in 
that age group. Bis the difference in dosage (mg/kg) between the lowest 
dosage that killed more than 50% of the mice in that age group and the 
highest dosage that killed less than 50% of the mice in that age,group. 
C is the difference.between 50% and the percentage of mice killed by the 
highest dosage killing less than 50% of the mice in the age group. Dis 
the difference between the lowest percentage of mice killed above.SO% and 
the highest percentage of mice killed below 50%. This method gives an 
approximate L.o. 50 which was satisfactory for comparing differences.in 
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susceptibility to HCP between the age groups of this experiment. 
When dosing these mice with the peanut oil solution of HCP, it was., 
found that the esophageal tube occasionally was accidentally passed into 
the trachea with the solution being deposited in the trachea and lungs. 
These mice were inunediately removed from the experiment, as they inevi-
tably died within 1-2 hours from asphyxiation. 
Insofar as posstble, each subgroup was made.up of an individual 
litter of mice, but in some·groups, two or more litters were used. No 
attempt was made to. classify the individual anim.als according to size, 
sex or pregnancy. All animals were dosed on the basis of body.weight. 
The solution was administered between ,10:00 and 12:00 A.M. to all groups, 
Food and water were available to the animals at all times both pre- and 
post-treatment. Unweaned mice were left with their mothers at all times. 
Results 
Five Day Mice. The youngest mice (5 days old) were originally given 
30, 60 and 90 mg/kg of HCP. It was found that HCP at the rate of 60 
mg/kg kiHed all these mice, and 30 mg/kg killed only one, Two addition-
al subgroups receiving 40 and 50 mg/kg were added in a further effort to 
determine the L.o. 50 more clo~ely. The experimental data.is sununari.zed 
in Table I. Thi.s data shows that the L.D. 50 for 5-day-old mice lies near 
35 m~/kg, The controls were dosed with an amount of peanut oil equal to 
that received by the 90 mg/kg group, One of the controls died, but this 
death was on the. fifth day after treatment and was attributed to a leak-
ing water dispenser which wet the bedding, causing chilling and death of 
this mouse. It did not appear that the control mouse died as a result of 
the peanut oil treatment. 
TABLE I 
MORTALITY RATE OF fIVE-DAY-OLD MICE TO SINGLE DOSES OF 
HEXACHLOROPHENE AT DIFFERENT LEVELSl,2 
Dose Litter 1 Litter 2 Fraction of No. Total No. Total 
HCP Killed Dosed Killed Dosed Killed 
Controls 
0% 1 5 0 5 0/10 
30 mg/kg 1 12 0 5 1/17 
40 mg/kg 3 4 4 4 7/8 
50 mg/kg 4 4 5 5 9/9 
60 mg/kg 7 7 3 3 10/10 
90 mg/kg 9 9 1 1 10/10 
lL,D,50 "' 35 mg/kg. 











This group of mice showed very few signs of HCP toxicity prior to 
death, The baby mice continued to nu:rse in an apparently normal manner 
until immediately prior (1 hour. or less) to thei.r demise. Most mice died 
approximately 22-28 hours after treatment. In almost all cases, mice 
which did not die within 48 hours after treatment survived the HCP 
toxicity •. 
Terminally, the mice became hyperpneic, dyspneic, cyanotic, and died 
in convulsions. These signs.were seen only in those mice that died and 
occurred less than one hour prior to death. No signs of toxicity were 
seen in those mice which s~rvived. 
Ten Day Mice. 
30, 60 and 90 mg/kg. 
The 10-day-old mice were originally dosed with HCP at 
It was found that these dosage rates killed 27 of 28 
mice .(Table II). As this was not the anticipated result, another series 
of mice was treated with the HCP solution at the 30 mg/kg dosage. The 
results were similar. A fourth subgroup of mice was then given HCP at 
the rate of 20 mg/kg. This dosage rate killed 20% of the mice, From 
this data, an L.o. 50 near 24 mg/kg for 10-day-old mice can be extrapo-
lated. The L.D. 100 would be slightly over 30 mg/kg. 
The control mice were given the same volume of peanut·oil as the 
mice receiving 90 mg/kg of.1% HCP solution. One of these controls was 
found dead due to undetermined causes 129 hours after being given the 
peanut oil. At the time .the dead control was discovered, it was too. 
autolyzed to determine the exact nature of .its death. 
Signs shown by these mice were similar to those.in the 5-day-old 
mice in that the baby mice appeared normal until shortly before their. 
time of death. About 30 to 60 minutes be{ore,death, the mice would be~ 
come quite inactive, show difficulty in breat}J.ing and then progress into 
TABLE II 
MORTALITY RATE OF TEN-DAY-OLD MICE TO SINGLE DOSES OF 
HEXACHLOROPHENE AT DIFFERENT LEVELSl,2 
Dose Litter 1 Litter 2 Fraction of No. Total No. Total 
HCP Killed Dosed Killed Dosed Killed 
Controls 
0% 1 6 1/6 
20 mg/kg 1 5 1 5 2/10 
30 mg/kg 10 11 4 5 14/16 
60 mg/kg 8 8 3 3 11/11 
90 mg/kg 9 9 3 3 12/12 
lL,D.50 "' 24 mg/kg. 
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terminal convulsions. No gastrointestinal disturbances were noted. The 
mice continued to nurse and act nonnal:J,y until the terminal episode, 
which usually occurred 18 to 24 hours ,after administration of HCP. The 
maximum time from administration of the drug until death was 38 hours, 
As with all other age groups, individual mice that lived past 48 hours 
usually made a full recovery. 
Fifteen Day Mice. Four subgroups were used in the 15-day-old age 
group, these being treated with HCP at the rates .of 30, 60, 90 and 120 
mg/kg, respectively. The data in Table III shows that the ,L.o. 50 lies 
between 30 and 60 mg/kg. Extrapolation g~ves._a figure near 45 mg/kg as. 
the dose which would kill 50 percent of the mice .. An L.o. 100 appears to 
be slightly over 90 mg/kg of HCP. 
Signs shown.by the fifteen-day~old mice were,more.noticeable than in 
the previous two groups. These mice died more quickly than the.two 
younger groups, most of them dying in a period 16-20 hours after admin-
istration of the ,drug. One mouse died after 32 hours, and some died as 
early as six hours after treatment.. These mice showed, lethargy and weak-
ness within a few hours after drug administration, They developed a 
pec~liar "flattening" of t]:ie rear qu~rters, with the rear legs abducted 
in a spread-eagle fashion, The rear legs .were functional, as were the, 
front legs, but there was a definite weakness in use of the rear legs, 
This weakness may have been,neurqlogical or muscular in origin; Dyspnea, 
hyperpnea,and convulsions developed during the one to two hours immedi-
ately priqr to death. Some mice se~med to become.extremely weak and.died 
with .no apparent respiratory involvement.or convulsions. 
The con1;:rols received the ,same.volu~e of peanut oil as the group 
which received 120 mg/kg of 1% HCP solution. The controls showed.no 
TABLE III 
MORTALITY RATE OF FIFTEEN-DAY-OLD MICE TO SINGLE DOSES OF 
HEXACHLOROPHENE AT DIFFERENT LEVELSl,2 
Dose Litter 1 Litter 2 Litter 3 Fraction of No. Total No. Total No. Total Killed HCP Killed Dosed Killed Dosed Killed Dosed 
Controls 
0% 0 4 0 3 0/7 
30 mg/kg 2 10 2/10 
60 mg/kg 7 9 2 3 3 3 12/15 
90 mg/kg 6 6 3 4 9/10 
120 mg/kg 10 10 2 2 12/12 
lL,D,50 ::: 45 mg/kg. 











Thirty Day Mice. The thirty-day-old mice were divided into four 
subgroups which received 90, 120, 150 and 180 mg/kg of HCP in a 1% 
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peanut oil solution, respectively. The data from this part of the study 
made it difficult to draw definite conclusions concerning an L.D. 50 . 
There was much variability in susceptibility to HCP between the litters 
of mice used. The data in Table IV shows that the L.D. 50 lies between 
90 and 150 mg/kg. Preliminary studies indicated the L.D. 50 of HCP for 
thirty-day-old mice to be within a range of 120 to 150 mg/kg. As seen in 
Table IV, the problem appears to be with the second litter of 30-day-old 
mice used in the subgroup treated with 120 mg/kg. All of this litter 
(nine of nine) died from a dose of 120 mg/kg of HCP, possibly indicating 
some unknown factor in this litter making them more susceptible to HCP 
toxicity. The results of the subgroups receiving 90, 150 and 180 mg/kg 
;supported the previous data that the L.D. 50 of HCP for 30-day-old mice 
was in the approximate area of 130 to 140 mg/kg. By omitting the sub-
group receiving 120 mg/kg of HCP, an L.D. 50 near 132 mg/kg was obtained 
by extrapolation. 
Definite neurological signs were noted in this group. "Flattening" 
or abduction of the rear legs was noted in almost all mice. The front 
legs were not involved. Weakness and inactivity were common signs. The 
mice became depressed and developed rough hair coats within a few hours 
after administration of HCP. Diarrhea was noted in some mice. Ptosis 
was noted in affected mice and the eyes appeared duller than in non-
affected mice. Some of these mice died as early as three hours after 
receiving the HCP. Most deaths occurred 12 to 20 hours after administra-
tion,.but a few mice lingered as long as 144 hours, showing paraparesis, 
TAB.LE IV 
MORTALITY RATE OF THIRTY-DAY-OLD MICE TO SINGLE DOSES OF 
HEXACHLOROPHENE AT DIFFERENT LEVELs 1 , 2 
Dose Litter 1 Litter 2 Fraction of No. Total No. Total Killed . HCP Killed Dosed Killed Dosed 
Controls 
0% 0 5 0/5 
90 mg/kg 3 4 0 7 3/11 
120 mg/kg 0 2 9 9 9/11 
150 mg/kg 6 10 6/10 









1L.D. 50 ~ 132 mg/kg. The L.D. 50 obtained by omitting the subgroup 
treated witfi 120 mg/kg. 
2L.D. 100 ~ 120 mg/kg. 
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rough hair coats, diarrhea, and hyperpnea before dying. Convulsions were 
seen terminally .in about one-half of the animals. Again, as .in previous 
groups, if the animals survived 48 hours, in almost all cases they made a 
complete recovery and appeared normal by the end of the seven-day obser-
vation period. 
Controls.were given peanut oil at the same dosage as those mice re-
ceiving 180 mg/kg of 1% HCP solution. There were no fatalities in the 
control group, and all mice in this group were normal throughout the 
seven-day holding period. 
Sixty Day Mice. Sixty-day-old mice were divided into four treatment 
groups receiving 90, 120, 150 and 180 mg/kg of HCP. The extrapolated 
L.D. 50 of HCP is 142 mg/kg, with the L.D. 100 being slightly over 180 
m~/kg. Table V summarizes the results of HCP toxicity in this age group, 
Signs associated with this group were similar to the thirty-day-old 
mice, Abduction of the rear legs with typical flattening of the rear 
quarters was the most constant and obvious sign, This usually was seen 
starting 8 to 12 hours after drug administration, Rough hair c9ats, 
weakness, inactivity and diarrhea were other commonly observed signs. 
Rapid respiration was seen in most animals in the few hours immediately 
prior to death, Convulsions were seen only in a few animals. Terminally, 
the animals appeared to become progressively weaker and more inactive 
until death. No deaths occurred after 47 hours post-treatment, and all 
survivors.were normal and active at the end of the seven-day observation 
period. No residual effects of toxicity were noted. 
Controls received peanut oil at the same dosage as the mice 
receiving 180 mg/kg of 1% HCP solution. No controls died, and they ap-
peared normal and active throughout the one-week observation period, 
TABLE V 
MORTALITY RATE OF SIXTY-DAY-OLD MICE TO SINGLE DOSES OF 
HEXACHLOROPHENE AT DIFFERENT LEVELsl,2 
Dose Litter 1 Litter 2 Litter 3 Fraction of No. Total No. Total No. Total Killed HCP Killed Dosed Killed Dosed Killed, Dosed 
Controls 
0% 0 6 0/6 
90 mg/kg 1 11 1/11 
120 mg/kg 0 5 0 3 3 5 3/13 
150 mg/kg 6 10 6/10 
180 mg/kg 9 11 9/11 
lL"D'SO "' 142 mg/kg. 
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Brain Weights and Pathological Lesions in Mice 
Treated With a Single Oral Dose 
of Hexachlorophene 
31 
This part of the experiment was designed to determine gross and 
histopathological lesions and brain weights of mice treated with a single 
oral dose of a solution of HCP in peanut oil (1% weight:volume). A 1% 
solution of HCP in peanut oil from the same stock solution that was used 
in the first study was.used for this portion of the experiment, 
The same age groups of Swiss white mice used in the previous study 
were used in this experiment, i.e., S, 10, 15, 30 and 60-day-old mice. 
At least eleven mice in each age group were utilized. A minimum of five 
mice in each age group were given 1% HCP solution at dosage levels that 
would produce signs of toxicity and at least six mice were given peanut 
oil alone at the same dosage rate. When the treated mice started showing 
toxic signs, usually 10 to 24 hours after administration of HCP, the 
treated mice and the .controls were killed by severing the neck with scis-
sors. Because of the desire to use fresh tissues, only mice that were 
killed were used for this study, Mice that died from toxicity were not 
used. The brains were removed immediately and weighed, then transferred 
to 10% formalin solution. Representative samples of liver, int~stine, 
lung and myocardium were also removed and fixed in.10% formalin. The 
tissues were allowed to fix in the formalin solution for at least 48 
hours. Tissue sections at five microns thickness were made and stained 
with hematoxylin-eosin for histopathologic evaluation. The slides were 
coded and studied the first time without knowing whether the sections 
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were from treated or control mice. 
Five-day-old mice were given 20 mg/kg of HCP in the peanut oil solu-
tion. Six mice were given HCP, but one died from toxicity. The five 
remaining treated mice were killed 24 hours after HC,P administration, the 
brains weighed, and tissues saved for section. Six controls having re-
ceived peanut oil alone were killed at 24 hours and tissues were saved 
for comparison with the HCP treated mice. The data is presented in 
Table VI. 
Results 
In the five-day-old mice, no detectable signs of toxicity were noted 
at 20 mg/kg except for the one mouse that died. The five treated mice 
had an average brain weight of 0.214 gm (standard deviation± 0.0055). 
The six control mice had an average brain weight of 0.220 gm (standard 
deviation ± O. 0303). There was .no significant statistical difference 
between the brain weights of the two groups in the five-day mice. 
The ten-day-old mice were given HCP at the rate of 20 mg/kg (four 
mice) and 30 mg/kg (three mice). Twelve controls were given peanut oil 
at an equivalent dosage to that received by the 30 mg/kg group. The 
average brain weight of the HCP-treated group was 0.3314 gm (standard 
deviation± 0.015). Of the control mice, the average brain weight was 
0,3308 gm (standard deviation± 0.012). This data is summarized in Table 
VII. As with five-day mice, there was no significant statistical differ-
ence between the group receiving HCP and that group receiving only peanut· 
oil. 
A group.of nine 15-day~old mice were given HCP at the rate of 30 
mg/kg and one received a dose of 60 mg/kg. Eight control mice received 
TABLE VI 
BRAIN WEIGHTS AND HISTOPATHOLOGICAL INTERPRETATION OF EDEMA OF 
THE WHITE MATTER OF THE BRAIN IN 5-DAY-OLD MICE 
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Mouse Dose of Brain Received Received Relative Degree Weight 1, 2, 3 
Number HCP HCP No HCP of Vacuolation (mg/kg) (gm) in Brain 
1 30 .22 x 
2 30 .21 x + 
3 30 .21 x + 
4 30 .22 x + 
5 30 .21 x + 
6 0 .28 x 
7 0 .20 x 
8 0 .22 x 
9 0 .21 x 
10 0 .20 x 
11 0 .21 x 
lMean brain weight of HCP mice = ,214 gm; standard deviation, 
± .ooss. 
2Mean brain weight of control mice= .220 gm; standard deviation, 
± .0303; 
3The difference is not statistically significant. t cal = -,4327; t_ OS = 2. 262. 
TABLE VII 
BRAIN WEIGHTS AND HISTOPATHOLOGICAL INTERPRETATION OF EDEMA OF 
THE WHITE MATTER OF THE BRAIN IN 10-DAY-OLD MICE 
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Mouse Dose of Brain Received Received Relative Degree Weight 112 , 3 Number HCP HCP No HCP of Vacuolation (mg/kg) (gm) in Brain 
1 30 . 32 x + 
2 30 .32 x + 
3 30 . 32 x + 
4 0 .33 x 
5 0 .33 x 
6 0 . 32 x 
7 0 .35 x 
8 0 .33 x 
9 0 • 32 x 
10 20 .33 x + 
11 20 .36 x + 
12 20 .33 x + 
13 20 . 34 x + 
14 0 • 35 x 
15 0 .33 x 
16 0 .32 x 
17 0 . 35 x 
18 0 .32 x 
19 0 . 32 x 
lMean brain weight of HCP mice = .3314 gm; standard deviation, 
± .015. 
2Mean brain weight of control mice = .3308 gm; standard deviation, 
± .012. 
3The difference is not statistically significant. t = .0952; 
t_ 05 = 2 .110. cal 
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peanut oil at an equivalent dosage to that received by the 30 mg/kg mice. 
Brain weights for the treated mice averaged 0.395 gm (standard deviation 
± 0.0108). For the control mice, average brain weight was 0.379 gm 
(standard deviation± 0.0113). Data for this group is given in Table 
VIII. The brain weights of mice receiving HCP were significantly heavier 
(p < .025) than the control group. 
Six 30-day mice received 1% HCP in peanut oil at the dosage of 150 
mg/kg. Seven mice of the same age group received peanut oil at an 
equivalent dosage, as shown in Table IX. The controls and HCP-treated 
mice were sacrificed 12 hours after drug administration. Mean brain 
weight in the treated group was 0.4233 gm (standard deviation± 0.0234). 
Mean brain weight in the control group was 0.4214 gm (standard deviation 
± 0.0212). There was no statistical difference in the mean brain weights 
between the two groups. 
Six 60-day mice received 150 mg/kg of HCP and six mice of the same 
age received peanut oil at an equivalent dosage level. Average brain 
weight in the treated group was 0.483 gm (standard deviation± 0.0075). 
This data, presented in Table X, shows a statistically significant 
heavier brain weight for the group receiving HCP (p < • 001) than for the 
controls. 
Tissues for microscopic evaluation were taken transversely through 
the brain in three areas: anterior one third of the cerebrum, posterior 
one third of the cerebrum and through the area of the pons. 
Histopathologic examination of the hematoxylin and eosin stained 
sections of the.brain revealed numerous small; irregularly distributed, 
sometimes confluent, interstitial spaces in the white matter. No lesions 
were noted in the gray matter. The most consistent lesions were found in 
TABLE VIII 
BRAIN WEIGHTS AND HISTOPATHOLOGICAL INTERPRETATION OF EDEMA OF 


































































































lMean brain weight of HCP mice= .395 gm; standard deviation, 
± .0108. 
2Mean brain weight of control mice= .379 gm; standard deviation, 
± .0113. 
3rhere is a statistically significant difference in the brain weight 
weights of the two groups (p < .025). teal= 3.08; t. 025 = 2.49. 
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TABLE IX 
BRAIN WEIGHTS AND HISTOPATHOLOGICAL INTERPRETATION OF EDEMA OF 
THE WHITE MATTER OF THE BRAIN IN 30-DAY-OLD MICE 
Mouse Dose of Brain Received Received Relative Degree 
Number HCP 
Weight 1 , 2 , 3 
HCP No HCP of Vacuolation (mg/kg) (gm) in Brain 
1 150 .47 x + 
2 0 .46 x 
3 150 .42 x + 
4 150 .41 x + 
5 150 .41 x + 
6 150 .42 x + 
7 150 .41 x + 
8 0 .40 x 
9 0 .41 x 
10 0 .41 x + 
11 0 .41 x + 
12 0 .42 x 
13 0 ,44 x + 
lMean brain weight of HCP ,' .4233 gm; standard deviation, mice = 
± .0234. 
2Mean brain weight of control mice = ,4214; standard deviation, 
± .0212. 
3The difference between the two groups is not statistically signif-
icant. t l = 0.1538; t. 05 = 2. 201. ca 
TABLE X 
BRAIN WEIGJITS AND HISTOPATHOLOGICAL INTERPRETATION OF EDEMA OF 
THE WHITE MATTER OF THE BRAIN IN 60-DAY-OLD MICE 
38 
Mouse Dose of Brain Received Received Relative Degree HCP Weight 1 , 2 , 3 of Vaculoation Number (mg/kg) (gm} HCP No HCP in Brain 
1 150 .48 x + 
2 150 .49 x + 
3 150 .so x + 
4 0 .45 x 
5 0 .46 x 
6 0 .46 x 
7 150 .48 x + 
8 150 .47 x + 
9 150 .48 x + 
10 0 .47 x 
11 0 .45 x 
12 0 .46 x 
lMean brain weight of HCP mice = .473 gm; standard deviation, 
± .0105. 
2Mean brain weight of control mice = .458 gm; standard deviation, 
± .0078. 
3The difference is statistically significant at the p = .001 level. 
t cal = 4.811; t.001 = 4.581. 
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the brain stem. In all sections, this was the most severely affected 
area. Vacuolation was seen in the white matter tracts in the cerebellum, 
A similar vacuolated appearance was noted in the white matter of the 
cerebrum, especially noticeable in the fibers of the corpus callosum, 
lateral olfactory tract, and the internal capsule. The spaces were 
variable in size and shape and sometimes confluent one with another. 
They did not correspond to any of the perivascular spaces, No stainable 
material was seen in the spaces, and there was no cellular reaction 
around the spaces. Distribution of the lesions was similar in all 
except the younger age groups, in which lesions were more or less limited 
to the brain stem. Even though the vascular lesions responsible for the 
vacuolation is not apparent in the sections of tissue, it is interpreted 
to be edema because of its apparent lack of cellular or tissue fragment 
components and its definite space-occupying relationship. 
No gross lesions were seen in any animal necropsied. 
No histopathological lesions were found in the liver, kidney, 
intestine, lungs or myocardium. 
In the blind study of histopathological lesions of 73 treated and 
control mice, 66 were correctly classified as to HCP-treated or normal, 
Of the seven brains that were incorrectly classified, four normals were 
classed as having lesions similar to treated mice. Three HCP-treated 
mice were classed as having no lesions, This is an overall success ratio 
of 90% for correctly classifying the sections as coming from treated or 
control mice. 
Radioisotopic Studies on the Metabolic Fate of 
Hexachlorophene in Mice of Different Ages 
Materials 
Hexachlorophene (methylene-14c) was obtained from Mallinckrodt 
Company. There were 15.01 mgs of 14c-HCP in the sample with a total 
activity of 0.1 milliCuries. The purity was reported as greater than 
98%. The solvent used was peanut oil. 
Methods 
The 14c-HCP was diluted with peanut oil to 0.75% solution (weight: 
volume). Each 10 microliters of the solution contained .075 mg of 
14 6 C-HCP or a calculated dose of 1.2 x 10 d.p.m. When a diluted sample 
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of the radioactive solution was counted, the actual d,p.m, for this solu~ 
tion was determined to be 1.45563 x 106. 
The same age groups of mice as used in the previous experiments (5, 
10, 15, 30 and 60 days old) were used for this study. Five mice in each 
age group received 14c-HCP and two controls in each age group received no 
medication,. Mice that died less than 24 hours post-treatment were dis-
carded, In the five-day-old and sixty-day-old mice, an additional group 
of five mice was dosed with 14c-HCP in each age group. Two additional 
controls.were used in both five-day and sixty-day mice, Each treated 
mouse received 10 microliters of the 14C-HCP in peanut oil solution, or a 
dose of 1,455,630 d,p.m. The solution was administered with a 50-
microliter syringe through a polyethylene tube inserted into the 
esophagus of the mouse. 
In order to prevent "super-absorption" and "super-excretion" of·such 
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a small dose of HCP in the older mice, the three older age groups were 
given an additional amount of non-radioactive or "cold" HCP approximately 
equal to one-half of the L.o. 100 , as previously established in the 
earlier experiments. The 5 and 10-day mice received only .075 mg of 
14c-HCP, while the 15, 30 and 60-day mice received .075 mg of 14c-HCP, 
plus an additional dose of non-radioactive HCP. 
The controls received no medication. 
All mice were sacrificed by decapitation at 24 hours after adminis-
tration of HCP. Twenty-five microliters (.0263 gm) of blood was taken 
from each mouse (48). The entire brain of each mouse was removed. In 
the 5, 10 and 15-day mice, the entire liver was removed, but in the 30 
and 60-day mice, a weighed random sample of liver was taken. Liver 
weights are recorded in Appendix B. 
The tissue samples were immediately placed in 2 ml of absolute 
ethanol to precipitate the protein and dissolve the HCP. Micro glass 
beads were added to each sample an4 the tissues were finely ground to 
enhance extraction of as much HCP as possible. The samples were then 
dried under lights and hot air. The dried samples were then resuspended 
in 15 ml of Bray's solution, and were,allowed to stand for one week to 
insure maximum extraction of HGP, 1 Then the liquid portion of each 
sample was-transferred into a clean glass scintillation vial to remove 
glass beads and tissue residue. 
Radioactivity was detennined in,a Packard Tri-Carb Liquid Scintilla-
tion Counter. , Three 10-minute counts were obtained on each sample. 
1Bray's solution formula: 0.8 gm of 1,4-bis-[2-(5-Phenyloxazolyl)]-
benzene; 16.0 gm of 2,5-diphenyloxazol; 240 gm of napthalene; 400 ml of 
absolute methanol; 80 ml of ethylene glycol; dioxane sufficient to make 
4 liters of solution. 
Appropriate blanks and controls were used. A diluted (1:100) 14c-HCP 
dose was counted. The counts for each sample were corrected for back-
ground count, instrument efficiency and quench correction (Appendix A). 
Results 
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Appendices A and B present the detailed data and calculations in-
volved in this part of the experiment. Table XI and Figure 3 summarize 
this information. Figure 3 shows that in general, as the age of mice in..,. 
creased, the amount of HCP in the tissues studied decreased. In this 
data, there is a striking similarity between mean blood and brain levels 
of HCP in each age group. In all cases, the concentration of HCP in the 
liver was higher than in either the blood or brain. 
The values for the 10-day-old mice are quite different from what 
might be expected in that they are much lower than any of the other 
groups. This age group is the most susceptible to HCP toxicity, as shown 
in the previous experiments. Since the data indicate that they have the 
lowest levels of HCP in the tissues of any group, it seems rather likely 
that some.experimental error may have been involved. There could be two 
possibilities as to the source of this difference. First and most 
likely, is that the dosing apparatus failed to deliver the full volume of 
14c-HCP solution to the mice. The second possibility is that this par-
ticular litter of mice did not absorb the HCP for some intrinsic reason 
or that they were able to excrete it at a much faster rate than other 
mice. The first possibility would seem to be the most probable. 
Sample radiation counts that are less than four times that of back-
ground radiation are not usually considered significant. In this study, 
these figures and calculations have been shown and included in the data, 
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TABLE XI 
STATISTICAL SUMMARY OF TISSUE LEVELS OF HEXACHLOROPHENE 
Age Number of Mean HCP Levels Standard Mice in Tissue in Tissues Deviation (Days) Group (mg/kg x 10-6) (mg/kg x 10-6) 
5 10 Blood 4,030 ± 3,448 
Liver 13,793 ± 9,630 
Brain 4,504 ± 2,907 
10 5 Blood 93 ± 46 
Liver 885 ± 519 
Brain 128 ± 64 
15 5 Blood 2,700 ± 686 
Liver 20,385 ± 6,728 
Brain 2,615 ± 867 
30 4 Blood 1,125 ± 708 
Liver 5,201 ± 2,336 
Brain 768 ± 380 
60 8 Blood 865 ± 733 
Liver 3,661 ± 3, 713 
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Figure 3. Tissue Levels of Hexachlorophene in Different Aged Mice 
but net radiation counts less than 160 d.p.m. (four times background 
count) may not be significant. 
Discussion 
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Hexachlorophene has been shown.to have toxic properties by many in-
vestigators. Up until now no one had presented controlled experimen'l:,al 
data to indicate that younger animals were more susceptible to the toxic 
effects of HCP than were adults. The data presented in this work clearly 
indicates that young mice are much m9re likely to die from ingestion of 
HCP than older mice. However, it appears that the youngest mice are not 
the most susceptible to toxicity, since 10-day mice died at lower dosage 
levels than the five-day mice (Figure 2). After 10 days of age, the 
amount of ingested HCP required to kill mice increased rapidly. 
Several possible explanations are proposed to account for the in-
creased susceptibility of young animals to HCP. One possibility is that 
the "blood-brain" barrier is not established in.the infant mice, thereby 
allowing more HCP to enter the nervous tissue. If this were true, then 
there should have been a similar level of HCP in the blood and brain of 
younger mice, with a large difference.in the blood and brain levels in 
older mice. The data from the third part of this experiment showed that 
the relative levels of HCP in blood and brain tissues were very similar 
in each age of mice. This evidence indicates that a blood-brain barrier 
for HCP may not exist in mice. 
A second possibility which may account for the increased suscepti-
bility of young mice is that they a~e capable of absorbing HCP in larger 
quantities or at a faster rate than older mice. If this were true, then 
the levels of HCP in all tissues would have been expected to be higher 
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for the young mice than the older mice. The third part of the experiment 
gave support to this idea in that the quantity of HCP in the brain, blood 
and liver was much higher for the 5 and 15-day mice than for the 30 and 
60-day mice. The extremely low level of HCP in all tissues examined in 
the 10-day mice is discussed on page 42. It seems likely that this data 
is the result of experimental error. 
A third reason that young mice are more severely affected by lower 
levels of HCP than older mice may be that the relative absorption rate is. 
similar for all ages but that older mice are able to excrete or metabo-
lize the HCP at a much higher rate than the younger mice. The enzyme 
systems.necessary to metabolize the absorbed HCP may be more functional 
in older individuals. Experiments by Wit and Genderen (61) indicated 
that very little HCP is excreted in the urine of rats. It would seem 
likely then that the liver is the primary organ of detoxification of HCP, 
either by metabolism or excretion through the biliary system into the 
intestinal tract. The results of this experiment neither confirmed nor 
rejected this possibility, although the extremely high level of HCP in 
all samples of liver tissue in.relation to blood and brain levels sug~ 
gests that the liver is the excretory or detoxification organ for HCP in 
mice. 
As .noted in Figure 3, the blood levels of HCP were strikingly close 
to the brain levels. This would indicate that the passage of HCP from 
the blood into and out of the brain is.by a simple process of diffusion. 
If there were an active process involved which either pumped HCP into 
neural tissue or inhibited its passage from the blood into the brain, 
then there should be a marked difference in the levels of HCP in the 
blood and brain. 
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The histopathologic lesions of HCP in the brain are easily recog-
nized. In studying the sections of mouse brains without reference to 
whether the individual mouse was treated or untreated, there was a 90% 
success rate in correctly labeling the sections as being from treated or. 
untreated mice. In the routine fixation and staining of hematoxylin and 
eosin slides of central nervous tissue, some vacuolation is produced as 
an artifact. This was seen primarily in the immediate vicinity of the 
ventricles or near. the periphery .. of the brain. The vacuolation of the 
brain produced by HCP was much more extensive and recognizable than the 
artifactual vacuolation in most cases. Vacuolation was found in all 
parts of the brain in the white matter. The gray matter appeared to be 
histologically normal in all cases. Even small bundles of white fiber 
tracts which passed through gray matter, such as in the caudate-putamen 
nucleus, showed the "looseness" or separation of the fibers. Magee, et 
al. (31) described this change as interstitial edema of the white matter, 
He reported an increase in the weights and water content of rat brains 
showing this histological feature and interpreted these findings as evi-. 
dence of edema. Kimbrough (26) also report~d an.increase in the brain 
weights of rats given HCP. 
In two of the five age groups of mice, i,e,, 15 and 60-day mice, a 
statistically significant increase was noted in the brain weights of 
HCP-treated animals as compared to controls, It is possible that there 
would have.beensignificant brain weight increases in other groups, 
especially 30-day mice, if the brain weights had been recorded to three 
or four decimal places or if more mice had been used, 
The exact nature by which HCP produces edema of the white matter is 
not known. The lack of cellular response is not supportive of an 
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inflannnatory lesion. The data from this study and that presented by 
others (31,57) indicate that a blood-brain barrier plays little, if any, 
part in the process. The pattern.of distribution of lesions does not 
appear to be oriented around blood vessels, and it has been shown.that 
the gray matter of the rat is more vascular than the white matter (31). 
The evidence suggests that a vascular lesion appears to be unlikely. The 
only biochemical effect of HCP suggested in the literature indicates HCP 
uncouples oxidative phsophorylation (S,7,53). 
It is possible that the production and removal of free fluid 
from the central nervous system is of peculiar importance in 
its over-all metabolism and that a general disturbance, insuf-
ficient to impair the specific activities of the neurones 
themselves, may first show itself by a failure to deal 
efficiently with such an essential fluid turnover (31). 
This area needs much further study. 
Another finding in this experiment that requires additional study is 
the indication that 10-day mice are more.susceptible to HCP toxicity than. 
either 5 or 15-day mice. The radioisotope studies indicated that the 
10-day mice actually absorbed less HCP than Sand 15-day mice, but this 
could be.in error. If the 10-day mice actually absorbed less HCP and yet 
were still more susceptible to toxicity than any of the other age groups, 
then the mechanisms involved in HCP toxicity are probably exceedingly 
complicated, 
The results from this experiment also raised questions as to whether 
HCP is absorbed from the gut to a greater extent in young animals or is 
excreted or metabolized faster in older animals. The mode of excretion 
should be'studied further to determine if the liver is the detoxification 
organ, either by metabolism or by excretion into the biliary system. 
Another area which needs clarification is the mechanism by which HCP 
causes selective edema of the white matter of the brain. 
CHAPTER IV 
SUMMARY AND CONCLUSIONS 
Single doses of HCP administered orally in a 1% peanut oil solution 
to 5, 10, 15, 30 and 60-day-old Swiss white mice were found to cause 
death of the younger animals at a much lower dosage level than in the 
older animals. The L.D. 50 for 10-day-old mice was approximately 24 mg/kg, 
while that for 60-day-old mice was near 142 mg/kg. The 10-day-old mice 
appeared to be more susceptible to toxicity from HCP than were 5-day-old 
mice. 
Brain weights were recorded from mice receiving single doses of HCP 
in 1% peanut oil solution and from mice receiving only peanut oil at the 
same dosage rate. The 5, 10 and 30-day-old mice showed no statistically 
significant differences in brain weights between the treated and control 
mice, while the 15 and 60-day-old mice showed statistically significant 
differences in brain weights between the treated and control groups. 
Brain weights in the treated mice in the latter two age groups were 
heavier. 
Histopathological examination of the brains of mice receiving orally 
administered HCP revealed vacuolation of the white matter of sufficient 
degree that was readily distinguishable, in most cases, from the brains 
of mice receiving no HCP. This vacuolation was similar to that described 
in previous.HCP toxicity reports in humans and animals, The gray matter 
was not detectably affected. There were no signs of inflammation near 
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so 
the areas of vacuolation. 
14c-Labeled HCP was given orally to S, 10, 15, 30 and 60-day-old 
mice to determine the relative distribution of HCP in the tissues. Blood 
and brain levels at 24 hours after administration were, on the average, 
very similar when compared in mg of HGP per gm of tissue. Liver levels 
were much higher than brain or blood levels. Young mice had more.HCP in 
their tissues than older mice, even though older mice were given larger 
doses of HCP. 
Future investigations,,concerning HCP toxicity should include studies 
to determine how HCP is metabolized and excreted. Another area that 
needs to be explored is the differenc~ in gastrointestinal absorption 
rates of HCP in various age groups of animals. Finally, an effort should 
be made to determine the process by which HCP causes vacuolation of the 
brain. 
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Five-Day Mice, Group 1 
Mouse Average Minus Quench Net DPM Tissue CPM Per Background Per Number Sample (45 CPM) Correction Sample 
Control 1 Heart 53.2 8.2 .82 10.0 
Liver 78.0 33.0 .82 40.2 
Brain 57.2 12.2 .82 14.9 
Control 2 Heart 121.6 76.6 .82 93.4 
Liver- 94.2 49.2 .82 --60. 0 
Brain 56.4 11.4 .82 1.3. 9 
1 Heart 4,190.4 4,145.4 .82 5,055.4 
Liver 36,522.4 36,477.4 .82 44,484.6 
Brain 26,112.3 26,067.3 .82 31,789.4 
2 Heart 4,198.7 4,153.7 .82 5,065.5 
Liver 35,083.9 35 ,03S, 9 .82 42,730.4 
Brain 32,240.8 32,195'.8 .82 39,263.2 
3 Heart 574.2 529.2 .82 645.4 
Liver 6,751.2 6,706.2 .82 8,178.3 
Brain 4,215.0 4,170.0 .82 5,085.4 
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Five-Day,Mice, Group 2 
Mouse Average Minus Quench Net DPM Tissue CPM Per Background Per Number Sample (41 CPM) Correction Sample 
c.ontrol 3 Heart 45.9 4.9 .82 6.0 
Liver 65.7 24.7 .82 30.1 
Brain 64.9 23.9 .82 29.1 
Control 4 Heart 41.8 0.8 .82 1.0 
Liver 149.2 108.2 .82 132.0 
Brain 119.6 78.6 .82 95.9 
4 Heart 254.3 213.3 .82 260.2 
Liver 1,196.4 1,154.4 .82 1,409.6 
Brain 4 ,821. 7 4,780.7 .82 5,832.5 
5 Heart 2,480.8 2,439.8 .82 2,976.6 
Liver 31,339.1 31,298.1 .82 38,173.9 
Brain 20,646.5 20,605.5 .82 25,138.7 
6 Heart 1,646.5 1,605.5 .82 1,958.7 
Liver 31,107.6 31,066.6 . 8.2 37 ,901.3 
Brain 25,937.4 25,896.4 .82 31,593.6 
7 Heart 1,053.6 1,012.6 .82 1,235.4 
Liver 12,984.7 12,943.7 .82 15,791.3 
Brain 10,609.8 10,568.8 .82 12,893.9 
8 Heart 533.8 492.8 .82 601.2 
Liver 7,000.2 6,959.2 .82 8,490.2 
Brain 5,467.4 5,426.4 .82 6,620.2 
9 Heart 1,031.6 990.6 .82 1,208.5 
Liver 23,857.1 23,816.1 .82 29,055.6 
Brain 22,323.7 22,282.7 .82 27,184.9 
10 Heart 1,324.3 1,283.3 .82 2,565.6 
Liver 16,163.0 16,122.0 .82 19,661.0 
Brain 9,290.4 9,249.4 .82 11,284.3 
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Ten-Day Mice 
Mouse Average·. Minus Quench Net DPM·, 
Number Tissu~ CPM Per Background Corrections. Per Sample (45 CPM) . Sample 
Gontrol .1 Heart 43. 7 0 .82 0 
Liver 68.2 23. 2 .82 28.3 
Brain 50.4 5.4 .82 · 6.6 
Control 2· Heart 45.2 0.2 .82 0.2 
Liver 62.9 17.9 .82 21.8 
Brain 49.7 4.7 .82 5.7 
1 Heart 83.6 38.6 .82 · 47.1 
Liver 3,481.5 3,436.5 .82 4,190.9 
Brain 827.4 782.4 .82 954.1 
2 Heart 78,3 33.3 .82 40.6 
Liver 1,35.6.1 1,311.1 .82 1,598.9 
Brain 507.8 462.8 .82 564.4 
3 He a.rt 59.7 14.7 .82 17.9 
Liver 870.5 825.5 .82 1,006.7 
') 
Brain 336.6 291.6 • 82 · 355.6 
4 Heart 112.8 67.8 • 82 · 82.7 
Liver 4 ,142.2 4,097.2 .82 4,996.7 
Brain 1,204.9 1,159.9 .82 1,414.5 
5 He a.rt 84.7 39.7 .82 48.4 
.-Liver. 1,797.0 1,752.0 .82 2,136.6 
Brain 670.4 652.4 .82 762.7 
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Fifteen-Day Mice 
Mouse Average Minus Quench Net DPM 
Number Tissue CPM Per Background Correction Per Sample (45 CPM) Sample 
Control 1 Heart 51. 0 6.0 .82 7.3 
Liver 490.2 445.2 .82 542.9 
Brain 79.5 34.5 .82 42.1 
Control 2· Heart 47.5 2.5 .82 3.0 
Liver 217.5 172. 5 .82 210.4 
Brain 59.4 14.4 .82 17.6 
1 Heart 630.8 585.8 .82 714.4 
Liver 32,088.9. 32,043.9 .82 39,077,9 
Brain 9,282.1 9,237.1 ,82 11,264.8 
2 Heart 316.0 271.0 .82 330.5 
Liver 16,546.9 16,501.9 .82 20,124.3 
Brain 3,867.1 3,822.1 .82 4,661.1 
3 Heart 443.9 398.9 .82 486,5 
Liver 18,000.1 17,955.1 .82 21,896,5 
Brain 4,444.8 4,399.8 .82 5,365.6 
4 Heart 584.6 539.6 .82 658,0 
Liver 31,725.0 31,680.0 .82 38,634.1 
Brain 7,707.0 7,662.0 ,82 9,343.9 
5 Heart 504.8 459,8 .82 560.7 
Liver 30, 724. 6 30,679,6 .82 37,414.1 
Brain 7,290,5 7,245.5 ,82 8,836.0 
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Thirty-Day Mice 
Mouse Average Minus Quench Net DPM 
Number Tissue CPM Per Background Correction Per Sample· (45 CPM) Sample 
Control 1· Heart 52.3 7.3 .82 8.9 
Liver· 86.4 41.4 .82 50.5 
Brain 56.7 11. 7 .82 14.3 · 
C.ontrol 2 Heart 49.0 4.0 .82 4.9 
Liver 86.6 41.6 .82 50.7 
Brain 54.0 9.0 .82 11.0 
1 Heart 56.2 11.2 .82 13.7 
Liver 393.5 348.5 .82 425.0 
Brain 210.5 165.5 .82 201.8 
2 Heart 8.4 .1 39.1 .82 47.7 
Liver 948.4 903.4 .82 1,101.7 
Brain 447.2 402.2 .82 490.5 
3 Heart 56.7 11. 7 · .82 14.3 
Liver 1,979.9 1,934.9 .82 2,359.6 
Brain 56.7 205. 7 ·.· .82 250.9 
4 Heart 69.4 24.4 .82 29.8 
Liver 689.3 644.3 .82 785.7 
Brain 220.4 175.4 .82 213.~ 
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Sixty-Day Mice, Group 1 
Mouse Average Minus Quench Net DPM 
Number Tissu.e CPM Per Background Correction Per Sample (45 CPM) Sample 
Control 1 Heart 47.4 2.4 .82 2.9 
Liver 56.4 11.4 .82 13.9 
Brain 48.6 3.6 .82 4.4 
Control 2 Heart 43. 8 0 .82 0 
Liver 48.3 3.3 .82 4.0 
Brain 43.6 0 .82 0 
1 Heart 44.4 0 .82 0 
Liver 124.7 79.7 .82 97.2 
Brain 55.6 10.6 .82 12.9 
2 Heart 52.7 7.7 .82 9.4 
Liver 316.9 271.9 .82 331.6 
Brain 91.0 46.0 .82 56.1 
3 Hee.rt 48.0 3.0 ,82 3.7 
Liver 204.8 159.8 .82 194.9 
Brain 75.2 30.2 .82 36.8 
4 Heart 44.0 0 . 82 · 0 
Liver 57.6 12.6 .82 15.4 
Brain 48.6 3.6 .82 4.4 
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Sixty-.Day Mice, Group 2 
Mouse Average Minus Quench Net DPM 
Number Tissue CPM Per Background Correction Per. Sample ( 41 CPM) Sample 
Control 3 Heart 43.8 2.8 .82 3.4 
Liver 57.6 16.6 .82 20.3 
Brain 41.3 0.3 .82 0.4 
Control 4 Heart 42.0 1.0 .82 1.2 
Liver 202.5 161.5 .82 197.0 
Brain 50.0 9.0 .82 11.0 
5 Heart 57.9 16.9 .8.2 20.6 
Liver 933.0 892.0 .82 1,088.2 
Brain 225.0 184.0 .82 224,5 
6 Heart 62.7 21. 7 .82 26.5 
Liver 2,554,3 2,513.3 .82 3,066.2 
Brain 331.4 290.4 .82 354, 3 
7 Heart 57.4 16.4 .82 20.0 
Brain 505.1 464.1 .82 566.2 
8 Heart 51.4 10.4 ,82 12.7 
Liver 1,267.2 1,226,2 .82 1,496.0 
Brain 277, 2 236. 2 .82 288.2 
APPENDIX B 
14C-HEXACHLOROPHENE LEVELS IN BLOOD, LIVER AND 
BRAIN OF DIFFERENT AGED MICE 
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Five-Day Mice, Group 1 
Weight 14C-HCP Total Dose DPM % of Dose Mg of HCP Mouse of Adm HCP of Tissue per of 14c-HCP per gm of Number Mouse (mg) Adm HCP Total per Organ Tissue (gm) (mg) (mg/kg) Organ (xio-6) 
Control 2.8 0 0 0 Heart 1 96 .0066 19 
1 Liver2 40 .0027 23 
Brain3 15 .0010 3 
Control 2.6 0 0 0 Heart 831 .057 183 
2 Liver 60 .0041 38 
Brain 14 .0010 3 
1 2.6 .075 .075 29 Heart 44,980 3.090 9,904 
Liver 44,480 3.056 28,650 
Brain 31,789 2.184 7,280 
2 2.6 .075 .075 29 Heart 45,069 3.096 9,924 
Liver 42,730 2.936 27,520 
Brain 39,263 2.697 8,991 
3 2.6 . 075 . 07S 29 Heart 5,742 .394 1,264 
Liver 8,178 .562 5,266 
Brain 5,085 .349 1,165 
1Blood weight of mouse is 9% of body weight (45). Bloo-d specific gravity is 1. 052 ( 48). Blood sample 
was 25 microliters. 
2Average liver weight was 3.06% of body weight. Th~ entire liver was used. 
3Average brain weight was .225 gm. The entire brain was used. 0\ 
CJ"1 
Five-Day Mice, Group 2 
Weight 14C-HCP Total Dose DPM % of Dose Mg of HCP Mouse of Adm HCP of Tissue per of 14c-HCP per gm of Number Mouse Adm HCP Total Tissue 
(gm) (mg) (mg) (mg/kg) Organ per Organ (x10-6) 
Control 2.9 0 0 0 Heart 1 60 .0040 11 
3 Liver2 30 .0020 17 
Brain 3 29 .0020 6 
Control 3.2 0 0 0 Heart 11 .0008 2 
4 Liver 132 .0090 68 
Brain 96 .0070 22 
4 3.8 .075 .075 20 Heart 3,384 . 232 510 
Liver 1,410 .097 626 
Brain 5,833 .401 1,336 
5 3.4 .075 .075 22 Heart 34 ,633 2.379 5,831 
Liver 38,174 2.623 18,912 
Brain 25, 139 1. 727 5,756 
6 3.3 .075 .075 23 Heart 22 ~119 1.520 3,837 
Liver 37,901 2.604 19,335 
Brain 31,594 2.170 7,235 
7 3.0 • 075 .075 25 Heart 12,683 . 871 2,420 
Liver 15,791 1.085 8,843 
Brain 12,894 .886 2 ,952. 
8 2.9 • 075 .075 26 Heart 5,966 .410 1,178 
Liver 8,490 .583 4,915 
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ls1ood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microli ters .. 
2Average liver weight was 3.06% of body weight. The entire liver was used. 
3Average brain weight was .225 gm. The entire brain was used. 
"' -..J 
Ten-Day Mice 
Weight 14C-HCP Total Dose Mouse of Adm HCP of Tissue Number Mouse (mg) Adm 
HCP 
(gm) (mg) (mg/kg) 
Control 5.3 0 0 0 Heart1 
1 Liver2 
Brain3 
Control 4.8 0 0 0 Heart 
2 Liver 
Brain 
1 5.4 .075 .075 14 Heart 
L1ver 
Brain 
2 5.0 .075 .075 15 Heart 
Li.ver 
Brain 
3 5.3 .075 .075 14 Heart 
Liver 
Brain 
4 5.6 .075 .075 14 Heart. 
Liver 
Brain 
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Mg of HCP· 


































Ten-Day Mice (Continued) 
Total Dose 
HCP of Tissue Adm HCP 
(mg) (mg/kg) 
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lBlood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microliters. 
2Average liver weight was 3.03% of body weight. The entire liver was used. 
3Average brain weight was .327 gm. The entire brain was used. 
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Fifteen-Day Mice 
Weight 14C-HCP HCP Total Dose Mouse of Adm Adm HCP of Number Mouse (mg) (mg) Adm HCP (gm) (mg) (mg/kg) 
Control 5.4 0 0 0 0 
1 
Control 5.9 0 0 0 0 
2 
1 5.3 . 075 .110 .185 35 
2 5.9 .075 .120 .195 33 
3 6.0 • 075 .120 .195 32.S 
4 5.3 .075 .110 .185 35 
DPM 
Tissue per Total 
Organ 
Heart 1 135 
Liver2 543 













Heart 11 ,934 
Liver 38,634 
Brain 9 ,344 
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Weight 14c-HCP HCP Mouse of Adm Adm Number Mouse (mg) (mg) (gm) 
5 5.4 .075 .110 
Fifteen-Day Mice (Continued) 
Total Dose 
HCP of Tissue Adm HCP 
(mg) (mg/kg) 
















Mg of HCP 






1Blood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microliters. 
2Average liver weight was 3.64% of body weight. The entire liver was used. 




Weight 14C-HCP Total Dose DPM 
% of Mg of 
Mouse of HCP HCP of Sample Organ Dose of HCP per Adm Adm Tissue Weight Weight per, 14c-HCP gm of Number Mouse Adm HCP Total 
(gm) (mg) (mg) (mg) (mg/kg) (gm) (gm) Organ per Tissug Organ. (xlO- ) 
Control 16.1 0 0 0 0 Heart1 .0263 1.45 491 .034 17-372 
1 Liver2 .21 1. 03 248 .017 12-264 
Brain3 .422 0.422 14 .001 2-37 
Control 16.2 0 0 0 0 Heart .0263 1.46 272 .019 10-205 
2 Liver .26 o. 77 150 .010 10-214 
Brain .422 0.422 11 .001 1-28 
1 18.8 .075 1. 7 1.775 94 Heart .0263 1.69 880 .060 635 
Liver .21 1.06 2,145 .147 2,468 
Brain .422 0.422 202 .014 583 
2 18.0 .075 1.6 1.675 93 Heart .0263 1.62 2,938 .202 2,087 
Liver .18 1.01 6,182 .425 7,043 
Brain .422 0.422 491 .034 1,337· 
3 16.0 .075 1.4 1.475 92 Heart .0263 1.44 783 .054 551 
Liver .33 0.92 6,578 .452 7,245 
Brain .422 0.422 251 .017 602 
4 16.4 .075 1.5 1.575 96 Heart .0263 0.0263 1,677 .155 1,226 
Liver .21 0.92 3,442 .236 4,048 
Brain .422 0.422 214 .015 548 
lBlood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microliters. 
2#C-1, C-2 and 3 are actual weights. #1, 2, and 4 are 5.62% of body weight. 
3Average brain weight was .422 gm. The entire brain was used. -'1 N 
Sixty-Day Mice, Group 1 
Weight 14C-HCP Total Dose DPM 
% of Mg of 
Mouse of HCP HCP of Sample Organ Dose of HCP per Adm Adm Tissue Weight Weight per 14C-HCP gm of Number Mouse Adm HCP Total 
(gm) (mg) (mg) (mg) (mg/kg) (gm) (gm) Organ per Tissue Organ (xlo-6) 
Control · · 30. 9 0 0 0 -~-0- Heart 1 .0263 2.78 307 .021 6-212 
1 Liver2 .33 1.80 76 .005 2-81 
Brain 3 .474 .474 4 .0003 0-18 
Control 33.8 0 0 0 0 Heart .0263 3.04 0 0 0 
2 Liver .33 1.96 24 .002 1-23 
Brain .474 .474 0 0 0 
1 30.7 .075 2.8 2.875 94 Heart .0263 2.76 0 0 0 
Liver .30 1. 78 577 .040 640 
Brain .474 .474 13 .001 53 
2 30.3 .075 2.7 2. 775 91 Heart .0263 2.73 976 .067 681 
Liver . 35 1. 76 1,667 .115 1,806 
Brain .474 .474 56 .004 225 
3 32.3 .075 2.9 2.975 92 Heart .0263 2.91 409 .028 287 
Liver .32 1.88 1,145 .079 1,245 
Brain .474 .474 37 .003 158 
4 32.5 .075 2.9 2.975 91 Heart .0263 2.93 0 0 0 
Liver . 31 1.89 94 .006 101 
Brain .474 .474 4 .0003 19 
lBlood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microliters. 
2Average liver weight was 5.81% of body weight. A weighed random sample of liver was used. 
3Average brain weight was .474 gm. The entire brain was used. -...J t,,l 
Sixty~Day Mice, Group 2 
Weight 14c-HCP Total Dose DPM 
% of Mg of 
Mouse of 
HCP HCP of Sample Organ. Dose of HCP per Adm Adm Tissue_ Weight Weight per 14c-HCP gm of Number Mouse Adm HCP Total 
(gm) (mg) (mg) (mg) (mg/kg) (gm) (gm) Organ per Tissue Organ (xl0-6) 
Contr-ol 
- - -
28.6 0 0 0 0 Heart1 .0263 2.57 332 . 023 - 7-231 
3 Liver2 .293 1.678 116 .008 4-124 
Brain 3 .418 .418 0.4 .000 0-2 
Control 27.9 0 0 0 0 Heart .0263 2.51 115 .008 2-81 
4 Liver .420 1.613 757 .052 24-838 
Brain .395 .395 11 .0008 1-49 
5 29.1 .075 2.6 2.675 92 Heart .0263 2.62 2,052 .14 1,439 
Liver • 347 1. 722 5,400 .37 5,763 
Brain- .461 .461 225 .015 895 
6 29.9 .075 2.7 2. 775 93 Heart .0263 2.69 2, 710 .19 1,921 
Liver .576 1.578 8,400 .58 10,148 
Brain .459 .459 354 .024 1,471 
7 30.7 .075 2.8 2.875 94 Heart .0263 2.76 2,099 .144 1,502 
Liver .463 1.439 
Brain .449 .449 566 .039 2,490 
8 35 • 075 3.2 3.275 94 Heart .0263 3.15 1,521 .104 1,086 
Liver .568 2.292 6,037 .415 5,926 
Brain .478 .478 288 .020 1,356 
1Blood weight of mouse is 9% of body weight (45). Blood specific gravity is 1.052 (48). Blood sample 
was 25 microliters. 
2Actual weight. 
3Actual weight. -..J ~ 
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